NCT06571162View on ClinicalTrials.gov

A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

September 30, 2028

Conditions
Atherosclerotic Cardiovascular Disease
Interventions
OTHER

Clinical Pharmacy Team

Patients will receive targeted care of their LDL-C through a pharmacist-driven management program.

OTHER

Usual Care

Patient will receive usual care for their LDL-C management.

Trial Locations (1)

84107

RECRUITING

Intermountain Healthcare Hospitals and Clinics, Salt Lake City

All Listed Sponsors
lead

Intermountain Health Care, Inc.

OTHER